ExodusPoint Capital Management, LP - CARDIFF ONCOLOGY INC ownership

CARDIFF ONCOLOGY INC's ticker is CRDF and the CUSIP is 14147L108. A total of 93 filers reported holding CARDIFF ONCOLOGY INC in Q1 2022. The put-call ratio across all filers is 1.69 and the average weighting 0.0%.

Quarter-by-quarter ownership
ExodusPoint Capital Management, LP ownership history of CARDIFF ONCOLOGY INC
ValueSharesWeighting
Q1 2022$45,000
-38.4%
18,164
+49.3%
0.00%0.0%
Q4 2021$73,000
-57.1%
12,164
-52.2%
0.00%
-50.0%
Q3 2021$170,000
-30.3%
25,461
-30.7%
0.00%
-33.3%
Q2 2021$244,000
-68.7%
36,764
-56.4%
0.00%
-72.7%
Q1 2021$780,000
+8.0%
84,252
+110.0%
0.01%
+57.1%
Q4 2020$722,00040,1130.01%
Other shareholders
CARDIFF ONCOLOGY INC shareholders Q1 2022
NameSharesValueWeighting ↓
CAXTON CORP 2,522,083$15,158,00012.39%
Octagon Capital Advisors LP 982,753$5,906,0001.15%
Altium Capital Management LP 337,000$2,025,0000.56%
ACT CAPITAL MANAGEMENT, LLC 102,500$616,0000.44%
Eventide Asset Management 1,670,399$10,039,0000.13%
Artal Group S.A. 750,000$4,508,0000.12%
Aquatic Capital Management LLC 8,000$48,0000.09%
ELKHORN PARTNERS LIMITED PARTNERSHIP 17,300$104,0000.06%
Anson Funds Management LP 69,381$417,0000.04%
KENNEDY CAPITAL MANAGEMENT LLC 170,447$1,024,0000.02%
View complete list of CARDIFF ONCOLOGY INC shareholders